Anticoagulants Flashcards

1
Q

Heparin mechanism

A

Binds ATIII inhibiting thrombin(IIa) and Xa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Heparin metabolism

A

Hepatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Heparin reversal

A

Protamine sulfate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

LMWH mechanism

A

Binds both ATIII and thrombin –> greater Xa than IIa (thrombin) inhib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

LMWH metabolism

A

Rental

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

LMWH reversal

A

Protamine sulfate (partial)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Fondaparinux mechanism

A

Xa indirect inhib (Arixtra)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Fondaparinux metabolism

A

Renal (Arixtra)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Fondaparinux reversal

A

None (Arixtra)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Warfarin mechanism

A

Vit K antagonist prevents synthesis of 10,9,7,2 C, S

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Warfarin reversal

A

Vit K, FFP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Aspirin mechansim

A

Irrev binds/inactivates COS, blocking production thromboxane A2 (prostaglandin for plt aggregation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Aspirin reversal

A

Plts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Rivaroxaban mechanism

A

Xa inhib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Rivaroxaban metabolism

A

Hepatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Rivaroxaban reversal

A

None

17
Q

Aspirin metabolism

A

Hepatic

18
Q

Heparin risks

A

HIT, bleeding

19
Q

LMWH risks

A

bleeding

20
Q

Fondaparinux risks

A

Highest bleeding risks

21
Q

Warfarin risks

A

adverse rxns with rifampin, phenobarbital, diuretics, cholestyramine

22
Q

Dabigatran mechanism

A

Reversible IIa inhibitor

23
Q

Dabigatran metabolism

A

renal

24
Q

Dabigatran antidote

A

Idarucizumab

25
Q

Dabigatran risks

A

GI upset, bleeding

26
Q

TXA mechanism

A

Compet inhib plasminogen by binding lysine binding site

27
Q

TXA risks

A

not associ with increased VTE